Related Experiment Video
Updated: Nov 11, 2025
Drug-Induced Sleep Endoscopy DISE with Target Controlled Infusion TCI and Bispectral Analysis in Obstructive Sleep Apnea
Published on: December 6, 2016
Prophylactic versus therapeutic caffeine for apnea of prematurity: a randomized controlled trial
Mohamed Elmowafi1, Nada Mohsen1,2, Islam Nour1,2
1Neonatal Intensive Care Unit, Mansoura University Children's Hospital, Mansoura, Egypt.
Insights
Early prophylactic caffeine therapy significantly reduces oxygen and respiratory support duration in preterm infants. This approach also lowers hospital stay and mild to moderate bronchopulmonary dysplasia incidence.
Area of Science:
- Neonatal Medicine
- Pediatric Pulmonology
- Clinical Pharmacology
Background:
- Methoxanthine therapy, including caffeine, is standard for apnea in preterm infants.
- Caffeine administration offers benefits for preterm infant outcomes.
Purpose of the Study:
- To compare the efficacy of early prophylactic versus routine therapeutic caffeine administration.
- To assess the impact on oxygen support duration and other key outcomes in preterm infants.
Main Methods:
- A randomized controlled trial compared prophylactic (within 72 hours) versus therapeutic (apnea-based) caffeine in preterm infants (<32 weeks gestation).
- Primary outcome: duration of oxygen therapy. Secondary outcomes: respiratory support duration, bronchopulmonary dysplasia (BPD), necrotizing enterocolitis, intraventricular hemorrhage, retinopathy of prematurity, length of hospital stay (LOS), neonatal mortality, and side effects.
Main Results:
- Prophylactic caffeine reduced oxygen therapy duration (28 vs. 34 days, p=0.005).
- Significantly decreased durations of respiratory support, LOS, and mild to moderate BPD incidence.
- Higher proportion of infants in the prophylactic group avoided mechanical ventilation during NICU stay.
Conclusions:
- Early prophylactic caffeine administration is effective in reducing oxygen therapy duration.
- Prophylactic caffeine lowers invasive/non-invasive ventilation needs, mild to moderate BPD, and LOS in preterm infants.
Background:
Therapeutic initiation of methyxanthines for treatment of apnea in preterm infants was the standard policy. Caffeine therapy is beneficial for various outcomes of preterm infants.
Aim:
To evaluate the efficacy of early prophylactic compared to routine therapeutic caffeine therapy on duration of oxygen support and other outcomes of preterm infants.
Methods:
In a randomized controlled trial including preterm infants < 32 weeks' gestation, prophylactic (in the first 72 h of life) versus therapeutic (only if apnea exists or infant requires mechanical ventilation) decision of caffeine was compared. The primary outcome was the duration of oxygen therapy. Secondary outcomes included duration of respiratory support modalities; bronchoplumonary dysplasia (BPD); necrotizing enterocolitis; intra-ventricular hemorrhage; retinopathy of prematurity; length of hospital stay (LOS); neonatal mortality; and caffeine side effects.
Results:
We enrolled 90 infants in the prophylactic and 91 infants in therapeutic groups respectively. Prophylactic caffeine decreased the duration of oxygen therapy [median and IQR of 28 (18-36) days versus 34 (23-51) days, p = .005 respectively]. Prophylactic caffeine significantly decreased the durations of respiratory support modalities, LOS, and incidences of mild to moderate BPD without reported effects on the incidence of severe BPD or other clinical outcomes compared to therapeutic caffeine. A significantly higher proportion of infants in the prophylactic caffeine group did not require mechanical ventilation during their NICU admission and a significant lower proportion required late mechanical ventilation compared to the prophylactic caffeine group.
Conclusion:
Prophylactic caffeine decreased the duration of oxygen therapy, invasive and noninvasive ventilation, incidences of mild to moderate BPD, and LOS in preterm infants.
More Related Videos
Related Concept Videos
01:16Experimental Designs
02:07Blind Procedures